CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,836 | -88.5% | 12,400 | -85.8% | 0.00% | -90.0% |
| Q2 2023 | $4,896,867 | -48.4% | 87,226 | -58.5% | 0.02% | -56.5% |
| Q1 2023 | $9,495,631 | +30.7% | 209,941 | +17.4% | 0.05% | -4.2% |
| Q4 2022 | $7,266,350 | -99.9% | 178,754 | +98.4% | 0.05% | +4.3% |
| Q3 2022 | $5,888,035,000 | -27.7% | 90,100 | -32.7% | 0.05% | -37.8% |
| Q2 2022 | $8,139,655,000 | -61.9% | 133,942 | -60.7% | 0.07% | -57.5% |
| Q1 2022 | $21,371,427,000 | +152.8% | 340,472 | +205.2% | 0.17% | +185.2% |
| Q4 2021 | $8,452,576,000 | -45.8% | 111,541 | -20.0% | 0.06% | -47.0% |
| Q3 2021 | $15,599,348,000 | +157.6% | 139,367 | +272.6% | 0.12% | +139.6% |
| Q2 2021 | $6,055,657,000 | -62.0% | 37,406 | -71.4% | 0.05% | -72.6% |
| Q1 2021 | $15,926,160,000 | +1653.7% | 130,703 | +1103.7% | 0.18% | +1490.9% |
| Q3 2020 | $908,163,000 | -25.1% | 10,858 | -34.2% | 0.01% | -42.1% |
| Q2 2020 | $1,212,585,000 | +116048.0% | 16,500 | -33.0% | 0.02% | +11.8% |
| Q1 2020 | $1,044,000 | +394.8% | 24,635 | +609.9% | 0.02% | +750.0% |
| Q4 2019 | $211,000 | -56.9% | 3,470 | -79.7% | 0.00% | -50.0% |
| Q4 2018 | $489,000 | -88.3% | 17,100 | -81.8% | 0.00% | -82.6% |
| Q3 2018 | $4,171,000 | – | 94,040 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |